Literature DB >> 11710581

Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatography.

K Wiwattanawongsa1, E L Heinzen, D C Kemp, R E Dupuis, P C Smith.   

Abstract

Simultaneous determination of mycophenolic acid (MPA) and mycophenolate phenol glucuronide (MPAG) in plasma and urine was accomplished by isocratic HPLC with UV detection. Plasma was simply deproteinated with acetonitrile and concentrated, whereas urine was diluted prior to analysis. Linearity was observed from 0.2 to 50 microg/ml for both MPA and MPAG in plasma and from 1 to 50 microg/ml of MPA and 5 to 2000 microg/ml MPAG in urine with extraction recovery from plasma greater than 70%. Detection limits using 0.25 ml plasma were 0.080 and 0.20 microg/ml for MPA and MPAG, respectively. The method is more rapid and simple than previous assays for MPA and MPAG in biological fluids from patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710581     DOI: 10.1016/s0378-4347(01)00354-1

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  6 in total

1.  Population pharmacokinetics of mycophenolic acid and metabolites in patients with glomerulonephritis.

Authors:  Wai-Johnn Sam; Melanie S Joy
Journal:  Ther Drug Monit       Date:  2010-10       Impact factor: 3.681

2.  Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Melanie S Joy; Tandrea Hilliard; Yichun Hu; Susan L Hogan; Jinzhao Wang; Ronald J Falk; Philip C Smith
Journal:  Ann Pharmacother       Date:  2009-06-02       Impact factor: 3.154

3.  Associations of UDP-glucuronosyltransferases polymorphisms with mycophenolate mofetil pharmacokinetics in Chinese renal transplant patients.

Authors:  Xiao-chun Xie; Jun Li; Hong-yang Wang; Hong-liang Li; Jing Liu; Qian Fu; Jia-wen Huang; Chen Zhu; Guo-ping Zhong; Xue-ding Wang; Ping-ping Sun; Min Huang; Chang-xi Wang; Jia-li Li
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

4.  Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis.

Authors:  Melanie S Joy; Tammy Boyette; Yichun Hu; Jinzhao Wang; Mary La; Susan L Hogan; Paul W Stewart; Ronald J Falk; Mary Anne Dooley; Philip C Smith
Journal:  Eur J Clin Pharmacol       Date:  2010-06-22       Impact factor: 2.953

5.  Pharmacokinetics of mycophenolic acid in patients with lupus nephritis.

Authors:  Melanie S Joy; Tandrea Hilliard; Yichun Hu; Susan L Hogan; Mary Anne Dooley; Ronald J Falk; Philip C Smith
Journal:  Pharmacotherapy       Date:  2009-01       Impact factor: 4.705

6.  Validated Simple HPLC-UV Method for Mycophenolic Acid (MPA) Monitoring in Human Plasma. Internal Standardization: Is It Necessary?

Authors:  Paweł K Kunicki; Aleksandra Wróbel
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.